Objectives The benefit of implantable cardiac defibrillator (ICD) in symptomatic patients with
systolic dysfunction and non-ischaemic cardiomyopathy remains controversial. We …

Objective The recent Danish Study to Assess the Efficacy of ICDs in Patients with Non-
ischemic Systolic Heart Failure on Mortality (DANISH) trial suggested that implantable …

Implantable cardioverter-defibrillator (ICD) has shown to reduce sudden cardiac death and
overall mortality in patients with dilated cardiomyopathy. The recently published DANISH …

Sudden cardiac death (SCD) accounts for approximately one-third of all deaths among
patients with non-ischaemic cardiomyopathy (NICM). Implantable cardioverter-defibrillator …

The evidence to support implantable cardioverter defibrillator (ICD) in subjects with
nonischemic cardiomyopathy (NICM) for primary prevention of sudden cardiac death (SCD) …

Importance Conflicting data have emerged on the efficacy of implantable cardioverter
defibrillators (ICDs) for primary prevention of sudden cardiac death (primary prevention …

Background Sudden cardiac death (SCD) is a significant cause of mortality in patients with
non-ischemic cardiomyopathy (NICM). Implantable cardioverter defibrillators (ICDs) are …

Background Implantable cardioverter defibrillators (ICD s) have proved their favorable
outcomes on survival in selected patients with cardiomyopathy. Although previous meta …

Aim Primary prophylactic implantable cardioverter defibrillators (ICDs) have demonstrated a
clear all-cause mortality benefit in patients with ischaemic cardiomyopathy, with less …

ICD for Nonischemic Cardiomyopathy Background Implantable cardioverter defibrillators
(ICDs) improve survival in patients with heart failure due to ischemic cardiomyopathy, but …